LUNG FUNCTION AND ASTHMA CONTROL IN PATIENTS ON MEDIUM-TO-HIGH-DOSE ICS-LABA: A SYSTEMATIC REVIEW OF THE OBSERVATIONAL LITERATURE

被引:0
|
作者
Czira, A. [1 ]
Meeraus, W. [1 ]
Martin, A. [2 ]
Turner, M. [2 ]
Birch, H. [1 ]
Zhang, S. [3 ]
机构
[1] GlaxoSmithKline, R&D Global Med, Brentford, England
[2] Evidera, Evidence Synth, Modeling & Commun, Waltham, MA USA
[3] GlaxoSmithKline, R&D Global Med, Collegeville, PA USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PRS64
引用
收藏
页码:S729 / S729
页数:1
相关论文
共 50 条
  • [31] Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with high-dose ICS/LABA therapy (on GINA step 5) prior to study entry: Results from IRIDIUM study
    Maspero, Jorge
    Kerstjens, Huib A. M.
    Chapman, Kenneth R.
    Van Zyl-Smit, Richard
    Tanase, Ana-Maria
    Lawrence, David
    Pethe, Abhijit
    Mezzi, Karen
    D'Andrea, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [32] Impact of benralizumab on asthma control, asthma-related quality of life and lung function in patients with poorly controlled eosinophilic asthma: A systematic review and meta-analysis
    Mahdavian, Masoud
    Brothers, Cassidy
    Asghari, Shabnam
    Mallay, Sarah
    Pike, Jordan
    CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2019, 3 (02) : 106 - 111
  • [33] High-altitude alpine therapy and lung function in asthma: Systematic review and meta-analysis
    Vinnikov, Denis
    Khafagy, Abdullah
    Blanc, Paul
    Brimkulov, Nurlan
    Steinmaus, Craig
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [34] REDUCTIONS IN EXACERBATIONS AND IMPROVEMENTS IN LUNG FUNCTION AND ASTHMA CONTROL IN CHILDREN WITH MODERATE-TO-SEVERE TYPE 2 ASTHMA ANALYZED BY HIGH- OR MEDIUM-DOSE OF INHALED CORTICOSTEROIDS AT BASELINE
    Maspero, J.
    Antila, M. A.
    Jain, N.
    Deschildre, A.
    Bacharier, L. B.
    Altincatal, A.
    Laws, E.
    Akinlade, B.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    Lederer, D. J.
    Hardin, M.
    VALUE IN HEALTH, 2022, 25 (12) : S34 - S35
  • [35] CAPTAIN Study: Effect of baseline lung function on response to triple therapy in patients with asthma inadequately controlled on inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) therapy
    Nathan, R.
    Boulet, L. -P.
    Kerstjens, H. A.
    Papi, A.
    Pavord, I. D.
    Hanania, N. A.
    Oppenheimer, J.
    Maselli, D. J.
    Liu, M. C.
    Weinstein, S.
    Mannino, D.
    Peachey, G.
    Zarankaite, A.
    Sule, N.
    Fowler, A.
    Lee, L.
    Kerwin, E.
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (01) : 88 - 88
  • [36] High versus Medium Dose of Inhaled Corticosteroid in Chronic Obstructive Lung Disease: A Systematic Review and Meta-Analysis
    Barakakis, Paraschos Archontakis
    Tran, Thuonghien
    You, Jee Young
    Romero, Gabriel J. Hernandez
    Gidwani, Vipul
    Martinez, Fernando J.
    Fortis, Spyridon
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 469 - 482
  • [37] Health Care Resource Utilization and Work Impairment for Asthma Patients Adherent to Medium- or High-Dosage ICS/LABA Fixed Combination Treatment: Findings From a US Real World Survey
    Davis, Jill R.
    Small, Mark
    Trudo, Frank J.
    Siddall, James
    Pike, James
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB59 - AB59
  • [38] Effects of omalizumab on lung function in patients with moderate-to-severe allergic asthma: a systematic review and meta-analysis
    Liao, Junyi
    Tang, Jia
    Jiang, Yuanping
    Wang, Youwen
    Ding, Jiali
    He, Yong
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2024, 18
  • [39] Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis
    Oba, Yuji
    Anwer, Sumayya
    Patel, Tarang
    Maduke, Tinashe
    Dias, Sofia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (08):